ARCHIVES

Dasatinib, Nilotinib Show Strong Early Results As Frontline Therapy For CML

This article is from The Cancer Letter archive.

Vol. 30 No. 12 | December 28, 2007

Download PDF Visit The Full Archive

Related Articles

In Brief: Cigarette Tax Would Raise $12 Million A Year for Pennsylvania Cancer Control, Research

August 5, 1977

Avon 1995 Grant Application Available

December 2, 1994

Avastin Combination Approved For Metastatic Colorectal Cancer

February 22, 2013

Task Force Urges HHS to Form Committee To Implement Genetic Testing Regulations

November 7, 1997

Eight Centers Picked To Host Regional Breast Cancer Summits

January 31, 1992

Prostate Cancer Council Calls For Long-Term Screening Research

September 10, 1993